Reducing Activities: company scaling back some business operations while continuing others

Stay Scaling Back

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world’s top 15 biopharmaceutical companies in terms of oncology sales.

Reducing Activities: company scaling back some business operations while continuing others

Stay Scaling Back
Revenue(RF), mln.USD
131
Assets(RF), mln.USD
63
Capital(RF), mln.USD
13
Glob.Revenue, mln.USD
3385
Staff(RF), 2021
277
Taxes(RF), mln.USD
4
The Company Statement
March 04, 2022

Continues serving patients. March 29, 2022 "In line with our relentless commitment to serving patients, we will continue to tackle their healthcare needs regardless of their race, sex, nationality, ethnicity, country of origin, language, or religion. We support global sanctions, and we will take all precautionary measures to comply with them. We have suspended several promotional activities in Russia, including advertising and participation to non-scientific congresses. Additionally, we will not initiate any new clinical trials." Revenue decreased in 2024 vs 2023 by more than -10%.

All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner